Medical Marijuana, Inc.

GRN Holdings Corporation Signs Letter of Intent for Corporate Restructuring

Retrieved on: 
Tuesday, January 17, 2023

ESTERO, Fla., Jan. 17, 2023 (GLOBE NEWSWIRE) -- GRN Holding Corporation, Inc. (OTC Pink: GRNF) is pleased to announce it has entered into a non-binding letter of intent for a corporate restructuring with Marijuana Inc. of Florida.

Key Points: 
  • ESTERO, Fla., Jan. 17, 2023 (GLOBE NEWSWIRE) -- GRN Holding Corporation, Inc. (OTC Pink: GRNF) is pleased to announce it has entered into a non-binding letter of intent for a corporate restructuring with Marijuana Inc. of Florida.
  • The Company expects to announce additional details regarding the proposed business consolidation when a definitive agreement is executed, which is expected in early 2023.
  • Any transaction would be subject to board and equity holder approval of both companies, regulatory approvals, and other customary conditions.
  • One World Legends has also brought “Landrace Strains” to the company enabling the growth and distribution of “Acapulco Gold”, “Panama Red”, and many others.”

Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology

Retrieved on: 
Tuesday, November 29, 2022

SAN DIEGO, CA, Nov. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway, has appointed two industry veterans to leadership roles within the organization; Mike Randolph as Executive Vice President and Mike Kolinski as Vice President of Information Technology.

Key Points: 
  • Mr. Randolph is a 31-year veteran of the industry bringing a combination of entrepreneurial spirit and a diverse professional background with him to Kannaway.
  • Newly appointed Vice President of Information Technology Mike Kolinski brings 25 years of industry experience, having worked in both sales and customer support roles, before taking on a leadership role in information technology where he has held the Vice President title for nearly two decades.
  • Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Hemp, Inc. Reports: Marijuana-Cannabidiol (CBD) Bill Signals New Era in Federal Cannabis Policy

Retrieved on: 
Tuesday, November 22, 2022

Passed by unanimous consent, by the Senate, the marijuana-related bill signals times are changing and so are perceptions about marijuana.

Key Points: 
  • Passed by unanimous consent, by the Senate, the marijuana-related bill signals times are changing and so are perceptions about marijuana.
  • 8454 - Medical Marijuana and Cannabidiol (CBD) Research Expansion Act marks a historic breakthrough in addressing the federal governments failed and misguided prohibition of cannabis.
  • ( Source )
    Per Congress.gov , the Medical Marijuana and Cannabidiol (CBD) Research Expansion Actwill:
    Establish a new, separate registration process to facilitate research on marijuana.
  • When the bill officially reaches President Joe Bidens desk, he will have 10 days (excluding Sundays) to sign or veto it.

Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results

Retrieved on: 
Tuesday, November 22, 2022

We will continue to target expansion of our brands as we work to build the worlds first truly global cannabis company.

Key Points: 
  • We will continue to target expansion of our brands as we work to build the worlds first truly global cannabis company.
  • Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties.
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

GRN Holdings Corporation, Inc. (OTC: GRNF) Provides Shareholder Update

Retrieved on: 
Tuesday, November 15, 2022

The last few months have given us the opportunity to solidify our relationship with our associates in the US and globally.

Key Points: 
  • The last few months have given us the opportunity to solidify our relationship with our associates in the US and globally.
  • Audit: We are now completing a 2 year audit with a PCOAB registered CPA firm (Hudgens CPA).
  • This starts the process to become a fully reporting company with the Securities and Exchange Commission in an effort to be fully transparent, provide reliable financial information and enhance shareholder value.
  • With their "Tell A Friend" model, GRN Holding is setting up for Farmer to Consumer distribution.

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Retrieved on: 
Tuesday, November 1, 2022

The story was also picked up via syndication by additional large outlets in Brazil including Boa Forma, Terra, O Tempo, and Hypeness, among others.

Key Points: 
  • The story was also picked up via syndication by additional large outlets in Brazil including Boa Forma, Terra, O Tempo, and Hypeness, among others.
  • We are thrilled that our products are enhancing lives and making a significant difference in the world, said HempMeds Brasil Executive Director Matheus Patelli.
  • Awaiting publication are two recent feature interviews with HempMeds Brasil for Bloomberg Brazil and Veja, one of Brazils biggest magazines.
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia

Retrieved on: 
Thursday, October 20, 2022

HempMeds Mexicos involvement in the industry-sponsored satellite symposia played an important role in complementing the main conference programs.

Key Points: 
  • HempMeds Mexicos involvement in the industry-sponsored satellite symposia played an important role in complementing the main conference programs.
  • Raul Elizalde, CEO of HempMeds, said in a statement: We are humbled to have been in a position to support the XII Latin American Congress of Epilepsy as a sponsor.
  • Medical Marijuana, Inc.'s headquarters are in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment

Retrieved on: 
Wednesday, October 12, 2022

"In our model, we studied the effect of CBD administered to mice that were in a parkinsonian state.

Key Points: 
  • "In our model, we studied the effect of CBD administered to mice that were in a parkinsonian state.
  • To ensure the most scientifically reliable, valid, and trustworthy results, HempMeds provided its flagship RSHO-X 5,000 to aid in the studys execution.
  • "Our commitment is to provide free access to non-psychoactive cannabis and its benefits, said Raul Elizalde, CEO of HempMeds.
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

TILT Holdings Launches Social Impact Driven Brand Black Buddha Cannabis in Massachusetts

Retrieved on: 
Thursday, October 6, 2022

PHOENIX, Oct. 06, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (TILT or the Company) (NEO: TILT ) (OTCQX: TLLTF ), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced the Massachusetts launch of Black Buddha Cannabis , a Black and woman-owned and led, environmentally conscious, social impact driven cannabis wellness brand.

Key Points: 
  • PHOENIX, Oct. 06, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (TILT or the Company) (NEO: TILT ) (OTCQX: TLLTF ), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced the Massachusetts launch of Black Buddha Cannabis , a Black and woman-owned and led, environmentally conscious, social impact driven cannabis wellness brand.
  • Black Buddha Cannabis is our eighth brand partner and the sixth brand weve brought to Massachusetts, further demonstrating our commitment to diversity in cannabis and the availability of quality products for patients and consumers.
  • There is a dearth of equity-driven cannabis brands in Massachusetts, and Black Buddha Cannabis helps to fill that void, said Roz McCarthy, Founder and Chief Executive Officer of Black Buddha Cannabis.
  • To keep up-to-date on progress, follow TILT and Black Buddha Cannabis on social media:
    TILT helps cannabis businesses build brands.

Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President

Retrieved on: 
Tuesday, October 4, 2022

Additionally, Bill Andreoli, the President of MFINITY Global will become the President of Medical Marijuana, Inc. subsidiary, Kannaway, LLC.

Key Points: 
  • Additionally, Bill Andreoli, the President of MFINITY Global will become the President of Medical Marijuana, Inc. subsidiary, Kannaway, LLC.
  • MFINITY products will be marketed and sold exclusively under the Kannaway brand and are now available for sale through Kannaway independent distributors and on Kannaway.com.
  • The asset purchase aligns with Medical Marijuana Inc.s newly implemented growth model of expansion via acquisition.
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.